Media

Meet The Disruptors: Jon Olsen Of Firefly Neuroscience On The Five Things You Need to Shake Up Your Industry

As a part of our series about business leaders who are shaking things up in their industry, I had the pleasure of interviewing Jon Olsen, CEO of Firefly Neuroscience.

Bright Minds, Firefly Neuroscience Shares Rise on Collaboration for Clinical Trial Analysis

Bright Minds Biosciences is working with Firefly Neuroscience, an AI healthcare company, to provide a full analysis of the electroencephalogram data in Bright Minds' Phase 2 clinical trial.

Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysis

In a recent collaboration with Bright Minds, Firefly employed its advanced AI-based BNA technology to analyze quantitative EEG data.

Firefly Neuroscience, Zeto Agree to EEG Headset Distribution Deal

The partnership will expand Firefly’s FDA-cleared BNA technology to more hospitals and physician offices.

Firefly and Zeto team up to distribute EEG headset devices

Firefly Neuroscience is now a non-exclusive distributor for Zeto’s pair of EEG-headsets, called WR19 and Zeto ONE.

Zeto inks partnership with Firefly Neuroscience

Zeto has formed a partnership with Firefly Neuroscience that boosts the distribution of Zeto’s FDA-cleared EEG headset devices.

AI medtech specialist Firefly lists on Nasdaq after merger

Canada's Firefly Neuroscience has completed a listing on the Nasdaq via a $45 million reverse merger with IT group WaveDancer, opening up new financing routes for its artificial intelligence-powered platform for measuring brain function.

Diagnostics World News Roundup

Roche announced the completion of the acquisition of LumiraDx’s Point of Care technology.

Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders

Firefly Neuroscience, Inc., an AI technology company developing innovative neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders, announced that it has formed a strategic partnership with the Neurology Consultants of Dallas to help enhance early detection efforts and disease management for patients suffering from cognitive decline.